Arrhythmia Monitoring Devices Market Worth $8.41 Billion By 2025

The global arrhythmia monitoring devices market size is expected to reach USD 8.41 billion in 2025 with a CAGR of 6.8% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.

Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.

In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/arrhythmia-monitoring-devices-market

Further key findings from the report suggest:

  • The arrhythmia monitoring devices market is highly competitive and is rapidly evolving with numerous potential market players
  • Holter monitors dominated the market in terms of revenue in 2017. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period
  • Atrial fibrillation dominated the market in terms of revenue in 2017. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices
  • Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation
  • The hospitals and clinics segment held the largest share in the market in 2017. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period
  • North America commanded the leading share in the market in 2017 due to faster regulatory approvals for innovative devices and procedures
  • AliveCor, Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; Fukuda Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare are some of the key players operating in this market.

Acute Repetitive Seizures Market Size Worth $3.19 Billion By 2025

The global acute repetitive seizures market size is expected to reach USD 3.19 billion by 2025, according to a new report by Grand View Research, Inc. The report also states that the market will expand at a strong CAGR of 47.8% during the forecast period. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/acute-repetitive-seizures-market

Further key findings from the study suggest:

  • Global acute repetitive seizures market size was estimated at USD 140.5 million in 2017 and is expected to register a CAGR of 47.8% over the forecast period
  • Diastat rectal gel was the dominant product segment in 2017 due to the efficacy of the route of administration and affordability of the product
  • USL-261 is expected to witness a lucrative CAGR over the forecast period. USL-21 has an edge over the other drugs owing to its superior clinical profile and positive phase III results
  • North America held the largest share in 2017 due to factors, such as growing initiatives for raising awareness about epilepsy and seizures
  • Germany is anticipated to witness lucrative growth over the next decade owing to technological advancements in scientific, clinical, and medical fields
  • Some of the key companies in the market are UCB S.A.; Neurelis, Inc.; and Alexza Pharmaceuticals, Inc. These companies are likely to dominate the market and gain maximum share over the forecast period

Sterility Indicators Market Worth $1.24 Billion by 2025

The global sterility indicators market size is expected to reach USD 1.24 billion by 2025, according to the study performed by Grand View Research, Inc. It is anticipated to expand at a CAGR of 10.9% over the forecast period. Strict regulations regarding healthcare products and high emphasis on sterility parameters and measures for the prevention of Hospital Acquired Infections (HAIs) are projected to drive the market growth.

Increasing number of geriatric population prone to chronic conditions is primarily driving the demand for drugs and medical devices globally.Governments in developing economies like India and China are focusing on providing cost-effective, high quality medications. The Union Cabinet of India has provided USD 13.16 billion to the National Health Mission (NHM) from April 2017 to March 2020. Currently, India has the highest U.S. Food and Drug Administration (FDA)-approved manufacturing facilities outside U.S. It also accounts for 22.0% of the overall approved U.S. FDA plants. Thus, demand for sterility testing services and products is anticipated to rise over the forecast period.

Standardized manufacturing protocols, introduction of novel products, and adoption of new technologies has led to harmonization of quality and sterility testing standards in the healthcare industry. This has created a need for not only aseptic manufacturing techniques but also for efficient and reliable sterilization monitoring processes. Furthermore, organizations such as the Agency for Healthcare Research and Quality and Centers for Medicare and Medicaid Services are also raising awareness about the need for stringent regulations for safety and quality testing services of healthcare products. Such steps are anticipated to bode well for expansion of the sterility indicators market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sterility-indicators-market

Further key findings from the report suggest:

  • Biological indicator segment captured the largest market share in 2017. Extensive usage as compared to chemical indicators owing to their reliability is anticipated to propel the segment growth
  • North America is expected to maintain its dominance with the largest market share over the forecast period owing to the presence of a large number of major companies and a high adoption of advanced technologies
  • Asia Pacific is expected to exhibit a lucrative CAGR during the forecast period. Presence of a large untapped market and availability of supportive government regulations are expected to attract global players
  • Some of the major players in the sterility indicators market include Getinge AB; Cantel Medical Corporation; 3M Company; Cardinal Health Inc.; Matachana Group; Mesa Laboratories; and Anderson Products Inc.

Building & Construction Sealants Market Worth $11.23 Billion By 2025

The global building and construction sealants market size is anticipated to reach USD 11.23 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.1% over the forecast period. Increasing construction spending in emerging economies like China and India is the significant factor driving market growth. Furthermore, the rising recovery of infrastructure in developed markets like U.S. and Germany is expected to boost the demand.

Water based sealant emerged as the leading technology worldwide in 2017 owing to its Volatile Organic Compound (VOC) free characteristics and low cost. These products minimize slipping while adhering to vertical surfaces and reduce the need for joint support during curing. Moreover, they are highly heat resistant and therefore the bond caused by them integrity when exposed to sunlight.

The silicone resin based sealants led the market in 2017 due to its characteristics such as thermal stability, adhesion, aesthetic appeal, and weather resistance. Furthermore, these products were significantly adopted for structural glazing and weatherproofing applications.

The bonding segment of the product captured the largest market share in 2017. For the purpose of bonding, construction sealants are always preferred over mechanical fasteners due to high strength bonding characteristics and better environment-friendliness. Also, they facilitate faster development of construction projects and are more economical than mechanical fasteners.

Asia Pacific is predicted to be the fastest growing region in the global building & construction sealants market, during the forecast period. Increasing demand for housing infrastructure coupled with rising per capita income is estimated to propel the construction sector in emerging economies like China, India, Vietnam, and Thailand. Moreover, there is an increasing demand for sustainable products, which is expected to support the growth of bio-based sealants.

The market is dominated by a few players who hold a significant market share. Major players are focusing on product differentiation and innovation to sustain the demand for eco-friendly products. Merger and acquisition is a significant strategy adopted by the industry players to gain a competitive advantage and expand their geographical presence.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/building-construction-sealants-market

Further key findings from the report suggest:

  • Polyurethane resin is expected to be the fastest growing segment with a CAGR of 6.0% during the forecast period on account of low cost and extensive usage in bonding applications
  • Flooring application led the building & construction sealants market in 2017, with a share of 23.1% owing to the enhanced bond strength and superior hardness offered by construction sealants for flooring purposes
  • The bonding function is anticipated to be the fastest growing function segment with a CAGR of 6.1% during the forecast period
  • Asia Pacific is predicted to lead with a market share of 47.7% by 2025 on account of rapid industrialization and rising spending on housing infrastructure
  • Regulatory agencies such as EPA and REACH have enforced strict regulations regarding the limits on the emissions of Hazardous Air Pollutants (HAP) and Volatile Organic Compounds (VOCs) which has encouraged the production of bio based sealants
  • Some of the key market players are Sika AG, 3M, Dow Corning, and H.B Fuller. New product launches, mergers and acquisitions, and product launches are the significant business strategies adopted by them.

Nordic Beverage Packaging Market Size Worth $2.18 Billion By 2025

The Nordic beverage packaging market size is projected to reach USD 2.18 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.5% CAGR during the forecast period. Increasing demand for non-alcoholic beverages is one of the key factors driving the regional market.

Rapid recycling rate of end-of-life beverage packaging products in Nordic countries has been contributing to lower costs of raw material. The Nordic region recycles approximately 51.0% of its waste every year. This has been solely driven by governments in numerous countries aiming for ban on landfills. These countries follow a general deposit-based system, which involves a surcharge on any beverage product that is refunded at the time of bottle/can deposit. This has resulted in high return rate of end-of-life products that can be recycled.

Beverage bottles, made of both glass and polyethylene terephthalate (PET), are preferred principally for their elegance on shelves and for their ability to hold greater product quantities compared to other beverage packaging solutions such as cans and pouches. PET bottles have been extensively used in Nordic countries for bottling beverages in order to increase the shelf appeal of beverages.

Sweden was the largest market for beverage packaging in 2017, and this trend is expected to continue over the forecast period. The market in this country is expected to witness stable growth over the forecast period owing to rising number of microbreweries in the region. In addition, the government of Sweden has recognized potential sustainability gains associated with plastic recycling. This development is expected to lead to growth of the bioplastic segment over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/nordic-beverage-packaging-market

Further key findings from the report suggest:

  • By product, the revenue bottles & jars segment is anticipated to reach USD 660.4 million by 2025. It is poised to post a CAGR of 3.5% during the forecast period
  • In terms of material, the plastic segment is expected to witness steady growth over the forecast period owing to increasing demand for non-alcoholic beverages in the region
  • On the basis of application, the non-alcoholic beverage packaging segment is anticipated to reach a market size of USD 1.16 billion by 2025, owing to increasing demand for packing of end products such as smoothies, mocktails, and juices
  • Some of the key companies present in the market are Amcor Limited; Mondi Plc; COVERIS; Bemis Company, Inc.; Ball Corporation, Tetra Laval International S.A, Stora Enso; and Crown Holdings, Inc.
  • Product innovation and technological advancements are two key areas of investment for major companies to sustain in the industry.

Wheat Germ Oil for Cosmetics Market Size Worth $8.90 Billion By 2025

The global wheat germ oil for cosmetics market size is likely to reach USD 8.90 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.6% during the forecast period. Increasing consumer disposable income coupled with the need to maintain a healthy lifestyle is expected to contribute to the demand for cosmetics made using essential oils, such as wheat germ oil. The plethora of application in skin and hair loss treatment, anti-aging massage, and aromatherapy are anticipated to fuel the demand for wheat germ oil.

Owing to easy availability, the demand for wheat is mainly driven by India, China, Australia, Russia, and Ukraine. Rising population and disposable income in the emerging economies of Asia and Africa are expected to have a positive impact on the wheat market. The increasing direct human consumption of wheat along with easy availability of feedstock is expected to play a crucial role in boosting the overall production of wheat. However, the availability of wheat to produce wheat germ oil is likely to decline over the forecast period with increasing global demand for food aligned with an escalating population.

Distribution channel is another significant factor contributing to the growth of the global wheat germ oil for cosmetics market. With the rising E-commerce industry, there is a huge potential for manufacturers to increase their profitability as the operating costs of online business lower than that of physical stores. The number of retailers has grown globally with the establishment of hypermarkets, supermarket, and drug stores, wherein, the increasing number of stores of major retailers has propelled sales in this market. Wide reach of these stores helps manufacturers to boost their customer base for cosmetics and personal care products thereby catering to the specific consumer requirements in the vicinity.

In terms of volume, Asia Pacific is projected to witness the fastest growth over the forecast period where China and India are among the leading market contributors. Significant growth of the regional cosmetics industry, driven primarily by countries such as India, China, Thailand, and South Korea, is anticipated to bode well for the global market. The region also accounts for a major portion of wheat germ oil production. Europe and North America are other major regions owing to their well-established and dynamic personal care industries. These industries are also responsible for the market growth in Central and South America and Middle East and Africa.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wheat-germ-oil-cosmetics-market

Further key findings from the report suggest:

  • Central and South America is projected to witness a CAGR of 3.5% in terms of revenue over the forecast years, to reach a market size of USD 208.5 million by 2025
  • Asia Pacific is expected to observe remarkable CAGR of 5.8% in terms of revenue during the forecast period owing to easy availability of raw materials which facilitates considerable reduction in production costs and result in higher margins for manufacturers
  • The market is partially consolidated and competitive in nature, with the presence of numerous multinational players
  • Some of the key companies present in the wheat germ oil for cosmetics market are Connoils, Panhandle Milling, John Aromas, Now Foods, Provital Group, AG Industries and Henry Lamotte Oils Gmbh.

Baby Cleaning Products Market Size Worth $4.99 Billion By 2026

The global baby cleaning products market size is expected to reach USD 4.99 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.3% during the forecast period. Rising awareness regarding baby hygiene, growing development of innovative cleaning products, and increasing disposable income of the populace in developed countries are some of the factors providing an upthrust to the market.

Incorporation of organic ingredients in baby cleaning products is expected to fuel the demand for these products. Earlier, the presence of harmful chemicals or ingredients such as sodium lauryl sulfate, phthalates, lanolin, and cornstarch in baby cleaning products resulted in several complications in babies such as rashes, irritation, and blisters. Thus, most parents avoid buying such products.

Market players are making efforts to incorporate organic ingredients in baby cleaning products. Major players such as Johnson & Johnson, P&G, and Kimberly-Clark Corporation have launched new product lines consisting of natural ingredients such as aloe vera, sesame oil, almond oil, and neem. For instance, Kimberly-Clark Corporation launched a new product line, Huggies Natural Care Plus Wipes, which consists of aloe vera and other natural ingredients. Such ingredients are skin-friendly and provide extra moisture to baby skin, leading to a relatively low risk of rashes and other complications.

Furthermore, GreenShield offers organic laundry detergents, which are devoid of any harmful chemicals and are suitable for cleaning baby clothes effectively. Such initiatives are likely to increase the usage of baby cleaning products over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/baby-cleaning-products-market

Further key findings from the report suggest:

  • In terms of revenue, the bottle wash segment is projected to expand at a CAGR of 6.0% during the forecast period. Rising initiatives pertaining to baby hygiene and increasing disposable income of people in developed countries are contributing to the growth of the segment
  • Asia Pacific is poised to witness the highest CAGR of 5.6% during the forecast period. Increasing birth rate, growing healthcare expenditure, and increasing disposable income are anticipated to escalate the growth of the regional market
  • Some of the key companies present in the market are Johnson & Johnson, Mayborn Group Limited, Nuby, Koninklijke Philips N.V., and Pigeon Corporation.

Neuroendocrine Tumor Treatment Market Size Worth $3.33 Billion By 2025

The global neuroendocrine tumor (NET) treatment market size is expected to reach USD 3.33 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to register a CGAR of 10.4% during the forecast period. Increasing pervasiveness of carcinoid tumors is expected to drive the market over the forecast period. Heavy investment in clinical trials by various pharmaceutical companies to develop novel products is another factor propelling the market development.

For instance, Novartis AG has the highest number of clinical trials followed by Pfizer Inc. and Ipsen Pharma. Moreover, technological advancements in therapies to treat neuroendocrine tumors are anticipated to fuel the market growth over the coming years. Some of these include PET imaging with Ga labeled Somatostatin, targeted drug therapies, and tyrosine kinase therapies. For instance, Lutathera by Novartis AG received FDA approval for the first ever radionucleotide therapy.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/neuroendocrine-tumor-net-treatment-market

Further key findings from the study suggest:

  • Somatostatin analogs segment accounted for the largest revenue share of more than 60% in 2017 owing to its cost-effective and safe therapy procedure
  • The pancreas segment is expected to exhibit the highest growth in the neuroendocrine tumor treatment market over the forecast period
  • Clinics segment is expected to register the highest CAGR of 10.9% over the estimated period due to increasing patient preference for clinics over other healthcare settings
  • North America held the largest share of the global neuroendocrine tumor treatment market in 2017 mainly due to favorable government insurance policies
  • Some of the key companies in the global market are Pfizer, Inc.; Novartis AG; Ipsen Pharma; and Boehringer Ingelheim International GmbH. Major companies focus more on R&D to develop novel therapeutics for NETs.

Nasal Drug Delivery Systems Market Worth $67.99 Billion By 2025

The global nasal drug delivery systems market size is expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR, according to a new report by Grand View Research, Inc. Rising awareness about nasal products is one of the major factors driving the market. Growing geriatric population is also expected to have positive impact on the market. According to the United Nations Department of Economic and Social Affairs, the global geriatric population (60 years and above), was around 962 million in 2017. The number is expected to grow, particularly in Latin America with 71% rise in population aged 60 and over, followed by Asia (66%), Africa (64%), North America (41%), and Europe (23%).

Moreover, ongoing product development and their expected commercialization will propel market growth over the forecast period. For instance, In April 2018, Dr. Reddy’s Laboratories, along with its subsidiary Promius Pharma, LLC, announced filing of their New Drug Application (NDA) for DFN-02, for the treatment of migraine. Increasing adoption of self-administration practices and focus on other alternative routes of drug delivery, such as nasal drug delivery, also offer growth opportunities for the market. Some of the key companies in the industry are AstraZeneca PLC; OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/nasal-drug-delivery-technology-system-market

Further key findings from the report suggest:

  • Nasal sprays led the dosage type segment in 2017 due to increased prevalence of asthma and other infectious diseases
  • On the other hand, nasal drops segment witnessed the fastest growth in 2017 owing to availability of cost-effective products with better efficacy
  • Non-pressurized containers segment led the market in 2017 due to continous development in nasal powders and gel products
  • Asthma was the dominant therapeutic application segment in 2017 and is estimated to be the fastest-growing segment with a CAGR of 7.0% during the forecast years due to increasing disease prevalence
  • Geographically, North America held the largest share in 2017. Asia Pacific is estimated to witness the fastest CAGR of 7.5% due to presence of key companies, such as Cipla Inc.
  • Some of the leading companies in the global nasal drug delivery technology market are GlaxoSmithKline PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty. Ltd.; and NAVEH Pharma Ltd.

Specialty NBR Market Size Worth $768.1 Million By 2025

The global specialty nitrile butadiene rubber market size is expected to reach USD 768.1 million by 2025 expanding at a CAGR of 4.2%, according to a new report by Grand View Research, Inc. Carboxylated NBR is expected to have a high market penetration on account of providing excellent resistance to oils and non-polar solvents. The demand for carboxylated NBR is likely to be driven by its ability to successfully replace polyurethane in the printing rubber roller application and to blend with various substances for durability, release, and temperature. Rising application of printing rubber rollers in abrasive products, glass industries, and conveying equipment is projected to drive the market growth.

Extensive usage of fillers in polymer processing for enhancing the mechanical properties as a result of rising awareness among buyers in automotive and construction sectors is projected to increase the demand for NBR. Gains in extrusion and calendaring segments in emerging economies including China and India on account of growing automotive and construction sectors are expected to fuel the product demand. Furthermore, application growth of gloves and masking tapes as a result of implementation of safety standards in the global manufacturing sector is expected to play a vital role in boosting the product usage in near future.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/specialty-nitrile-butadiene-rubber-nbr-market

Further key findings from the study suggest:

  • Increasing demand for plastic components across several end-use applications, such as packaging, automotive, medical devices, and home appliances, will drive the market
  • In terms of revenue, liquid NBR segment is projected to ascend at a CAGR of 3.9% over the forecast period
  • Carboxylated NBR was the dominant segment in 2018 and accounting for the largest share of the global specialty NBR market
  • Extrusion & calendering application segment dominated the market in 2018 and accounted for a share of 49.8%
  • Well-established automotive industry coupled with growing automotive aftermarket in U.S. is estimated to propel gear, friction bearing, and bushes applications. This is likely to fuel the product demand
  • Zeon Corporation, JSR Corporation, and Lanxess AG are projected to remain the key market leaders over the projected period
  • Product innovation and partnerships with buyers for the development of customized products are projected to remain critical success factors for the industry participants